Granite Point Capital Management, L.P. Matinas Bio Pharma Holdings, Inc. Transaction History

Granite Point Capital Management, L.P.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 10, 2020	SELL	$0.63 - $2.27 $945,000 - $3.41 Million	-1,500,000 Closed	0 $0
Q2 2019 Jul 29, 2019	SELL	$0.79 - $1.11 $162,845 - $228,808	-206,134 Reduced 12.08%	1,500,000 $1.29 Million
Q1 2019 May 14, 2019	BUY	$0.6 - $1.41 $1.02 Million - $2.41 Million	1,706,134 New	1,706,134 $1.86 Million

3.52M

Ticker MTNB
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,864,992
Market Cap $130M
Description
Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic ...

Get notified when there are updates to the investment portfolio of Granite Point Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Granite Point Capital Management, L.P. with notifications on news.